bexarotene has been researched along with Dermatitis Medicamentosa in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camacho, F; Carrizosa-Esquivel, A; Herrera-Saval, A; Rios-Martín, JJ; Ruiz-de-Casas, A | 1 |
| Assaf, C; Beyer, M; Lukowsky, A; Roewert-Huber, J; Steinhoff, M; Sterry, W | 1 |
| Bailly, C; Formstecher, P; Lansiaux, A | 1 |
| Duvic, M | 1 |
1 review(s) available for bexarotene and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Current treatment of Cutaneous T-Cell Lymphoma.
Topics: Administration, Oral; Administration, Topical; Anticarcinogenic Agents; Apoptosis; Bexarotene; Biopsy; Carmustine; Disease Progression; Drug Eruptions; Humans; Hypertriglyceridemia; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Neoplasm Staging; Prognosis; PUVA Therapy; Retinoids; Sezary Syndrome; Tetrahydronaphthalenes; Vitamin D | 2001 |
3 other study(ies) available for bexarotene and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Sézary syndrome associated with granulomatous lesions during treatment with bexarotene.
Topics: Adult; Antineoplastic Agents; Bexarotene; Drug Eruptions; Fatal Outcome; Female; Granuloma; Humans; Sezary Syndrome; Tetrahydronaphthalenes | 2006 |
Complete clinical remission of tumor-stage mycosis fungoides after acute extensive skin necroses, granulomatous reaction, and fever under treatment with bexarotene, vorinostat, and high-dose fenofibrate.
Topics: Acute Disease; Anticarcinogenic Agents; Bexarotene; Biopsy; Drug Eruptions; Female; Fenofibrate; Fever; Granuloma; Humans; Hydroxamic Acids; Hypolipidemic Agents; Middle Aged; Mycosis Fungoides; Necrosis; Remission Induction; Skin; Skin Neoplasms; Tetrahydronaphthalenes; Vorinostat | 2008 |
[LGD1069: an antagonist to the X retinoid receptor].
Topics: Animals; Anticarcinogenic Agents; Bexarotene; Cells, Cultured; Clinical Trials as Topic; Dimerization; Drug Eruptions; Drug Evaluation; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Lymphoma, T-Cell; Mice; Rats; Receptors, Retinoic Acid; Retinoid X Receptors; Skin Neoplasms; Structure-Activity Relationship; Tetrahydronaphthalenes; Transcription Factors; Transcriptional Activation | 2000 |